Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
IPO Year:
Exchange: NYSE
Website: humana.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
6/26/2024 | $392.00 | Overweight | Piper Sandler |
6/24/2024 | $374.00 | Equal-Weight | Morgan Stanley |
4/2/2024 | $470.00 → $342.00 | Buy → Neutral | BofA Securities |
4/2/2024 | Buy → Neutral | BofA Securities | |
3/22/2024 | Mkt Perform | Raymond James | |
3/13/2024 | Buy → Hold | Argus | |
3/6/2024 | $356.00 | Equal Weight | Barclays |
1/26/2024 | $391.00 | Overweight → Neutral | Cantor Fitzgerald |
1/25/2024 | $360.00 | Buy → Hold | Deutsche Bank |
12/12/2023 | $550.00 | Hold → Buy | Argus |
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
4 - HUMANA INC (0000049071) (Issuer)
David Dintenfass to lead new centralized function focused on customer experience, sales and marketing Leading health insurer and health care services company Humana Inc. (NYSE:HUM) announced today that it has named David Dintenfass as President of Enterprise Growth. In this new role, Dintenfass will have responsibility for leading the company's growth plan with a primary focus on customer acquisition, retention, and experience. The creation of this position, and its emphasis on the customer and digital experience, will help Humana deliver on its long-term strategy and maximize long-term growth within the Medicare Advantage market. By 2030, one in five Americans is projected to be 65 years
Broussard, who reimagined senior-focused health care, announces he will step down after more than a decade of serving at the helm of the company Leading health insurer and health care services company Humana Inc. (NYSE:HUM) announced today it has named health care industry veteran Jim Rechtin as President and Chief Operating Officer of Humana Inc., effective January 8, 2024, as part of a long-planned CEO transition. He will report to Bruce Broussard, CEO, until the latter half of 2024 at which time Broussard will step down and Rechtin will assume the CEO role. Broussard joined Humana in 2011 and assumed the role of CEO in 2013. Over the last decade, he has led the company's transformati
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE:HUM) for the past 41 years, today announced that David A. Jones Jr. has been elected to serve as Chairman of the Board of Directors, effective as of April 1, 2023. Jones is a current board member with over 26 years of dedicated service to the Humana Foundation. Since 1993, Jones has served on the Board of Directors for Humana Inc., a position from which he recently decided to retire as of April 20, 2023. "I am beyond honored with the opportunity to lead the Humana Foundation board and to further the 40-year history of the Foundation in Louisville, Kentucky and beyond as the foundation's reach has expanded nationally," said Mr.
Piper Sandler initiated coverage of Humana with a rating of Overweight and set a new price target of $392.00
Morgan Stanley initiated coverage of Humana with a rating of Equal-Weight and set a new price target of $374.00
BofA Securities downgraded Humana from Buy to Neutral and set a new price target of $342.00 from $470.00 previously
BofA Securities downgraded Humana from Buy to Neutral
Raymond James initiated coverage of Humana with a rating of Mkt Perform
Argus downgraded Humana from Buy to Hold
Barclays initiated coverage of Humana with a rating of Equal Weight and set a new price target of $356.00
Cantor Fitzgerald downgraded Humana from Overweight to Neutral and set a new price target of $391.00
Deutsche Bank downgraded Humana from Buy to Hold and set a new price target of $360.00
Argus upgraded Humana from Hold to Buy and set a new price target of $550.00
11-K - HUMANA INC (0000049071) (Filer)
11-K - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
10-Q - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
424B5 - HUMANA INC (0000049071) (Filer)
Walmart Inc. (NYSE:WMT) has reportedly entered discussions with prospective buyers to offload its recently closed medical clinics. In April, Walmart announced the shutdown of all 51 of its health clinics and terminated its virtual healthcare services, citing the unsustainable nature of the business model. The retail giant is now exploring options to recover some of its investments in the clinics, engaging in conversations with various entities, including health insurance company Humana Inc. (NYSE:HUM), reported Reuters. Walmart has expressed its aim to recoup investments through a sale or other takeover arrangements. Although it’s unclear whether these discussions are still active,
Humana Inc (NYSE:HUM) recently inked an in-network deal with the University of Alabama at Birmingham's (UAB) Health System to provide Medicare Advantage members in the state greater access to care. The leadership of the new CEO, Jim Rechtin, who is joining on July 1, could accelerate the company's turnaround, according to Piper Sandler. The Humana Analyst: Jessica Tassan initiated coverage of Humana with an Overweight rating and price target of $392. The Humana Thesis: The company's turnaround is "well underway," and earnings are likely to trough this year, Tassan said in the initiation note. Check out other analyst stock ratings. Humana has a "positive 6-month catalyst path,"
Piper Sandler analyst Jessica Tassan initiates coverage on Humana (NYSE:HUM) with a Overweight rating and announces Price Target of $392.
Morgan Stanley analyst Erin Wright initiates coverage on Humana (NYSE:HUM) with a Equal-Weight rating and announces Price Target of $374.
https://www.statnews.com/2024/06/21/medicare-coverage-wegovy-weight-loss-cancer-blood-tests-grail/
https://www.wsj.com/health/healthcare/medicare-will-recalculate-quality-ratings-of-medicare-advantage-plans-eebee409?mod=latest_headlines
Humana (NYSE:HUM) underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 3 9 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 2 0 0 2M Ago 1 2 2 0 0 3M Ago 2 1 4 0 0 Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $364.33, accompanied by a high estimate of $396.00 and a low estimate of $310.00. Experiencing a 8.61% decline, the current average is now l
Cantor Fitzgerald analyst Sarah James reiterates Humana (NYSE:HUM) with a Neutral and maintains $360 price target.
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
Humana Inc. (NYSE:HUM) will release its financial results for the second quarter 2024 (2Q24), as well as prepared management remarks (in PDF format), on Wednesday, July 31, 2024, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI4837b56336d1453fb10a8fdaada5e1c0. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique regi
Humana's Primary Care Organization employees are receiving military cultural competency training Conviva Care Center and CenterWell Senior Primary Care®, subsidiaries of Humana Inc. (NYSE:HUM), are partnering with PsychArmor, the leader in military culture training, to offer a Veteran Ready Healthcare Certificate program for healthcare providers and employees at 23 senior primary care centers across Texas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240626873769/en/Healthcare providers and support staff from Humana's Primary Care Organization are learning to identify common barriers to accessing healthcare for veterans thro
Move brings personalized care to more Louisiana seniors CenterWell Senior Primary Care® is entering the Baton Rouge and New Orleans metro areas, opening four new senior-focused primary care centers in the regions in 2024. Two centers – CenterWell Prairieville and CenterWell Baker – are located near Baton Rouge, and CenterWell Marrero and CenterWell Mid-City are located near New Orleans. These openings offer local seniors access to CenterWell's personalized, care-team approach to health care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240620862901/en/CenterWell Senior Primary Care Center Prairieville in Prairieville, Louisi
To celebrate America's most popular multigenerational sport, the National Mall of Pickleball will search for the Ultimate Intergenerational Duo to encourage healthy, active lifestyles and celebrate the connections made on – and off – the court this September on The National Mall The Trust for the National Mall, Humana (NYSE:HUM), and the Humana Foundation announced today that the National Mall of Pickleball is returning to America's Front Yard, the National Mall, for a second year with two additional courts and the professional D.C. Pickleball Team's (DCPT) newest roster, including Dekel Bar, Rachel Rohrabacher, James Ignatowich and Allyce Jones. This year's event, happening from Septembe
CenterWell Senior Primary Care® is opening two new senior-focused primary care centers in Asheville in 2024. This will mark the company's debut in the area, giving local seniors access to CenterWell's personalized, care-team approach to health care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240610755112/en/CenterWell Senior Primary Care Center River Hills in Asheville, N.C., is open and began seeing patients in April. CenterWell River Hills, located at 105 River Hills Road, Suite A, will celebrate its grand opening June 20, 10 a.m. to 1 p.m., and seniors are encouraged to come out, learn more about the center, and meet
Seamless Data Exchange Improves Patient Access to Care, Reduces Administrative Burden Across the Healthcare Ecosystem athenahealth, a leading provider of network-enabled software and services for medical groups and health systems nationwide along with collaborators Availity, Harmony Park Family Medicine, and Humana (NYSE:HUM), received a 2024 Points of Light Award from KLAS. The group's case study, "Using FHIR Standards to Streamline Prior Authorization Management & Improve Patient Care," recognized the organizations' work together to modernize the prior authorization process and expedite approval of prior authorization requests. This press release features multimedia. View the full rele
The University of Alabama at Birmingham (UAB) Health System and Humana, a leading health and well-being company, have signed an in-network agreement, expanding access to care for all Humana Medicare Advantage members in Alabama. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240603751242/en/The University of Alabama at Birmingham (UAB) Health System and Humana, a leading health and well-being company, have signed an in-network agreement, expanding access to care for all Humana Medicare Advantage members in Alabama. (Photo: Business Wire) Humana's Medicare Advantage members in Alabama now have in-network access to the following U
Has Nominated Seven Highly Qualified Independent Directors with Industry Expertise Who Can Help Drive Improved Operating Results Expresses Disappointment That Enhabit's Board Has Chosen Not to Engage Details Enhabit's Dramatic Operational Underperformance Reaffirms View of Substantial Unrecognized Value of Enhabit Files Preliminary Proxy Statement for 2024 Annual Meeting of Stockholders NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP, together with its affiliates, the owners of approximately 4.9% of the shares of Enhabit, Inc. (NYSE:EHAB) ("Enhabit"), today issued an open letter to its fellow stockholders regarding the need for a major boardroom change at Enhabi
Organization recognized for the Sixth Time in Seven Years CenterWell Specialty Pharmacy has received the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the sixth time in seven years. The award recognizes best-in-class customer satisfaction and commitment to patient care by a specialty pharmacy. "It's extremely gratifying to be recognized with an award of this stature and even more so because it represents the voice of the patient," said Guillermo Sollberger, senior vice president of CenterWell Specialty Pharmacy and CenterWell Pharmacy. "This reflects not only the hard work and dedication of our CenterWell Specialty Pharmacy teammates but also our ongoing com
Humana Inc. (NYSE:HUM) has ascended to No. 6 on Fair360's prestigious list of the Top 50 Companies for Workplace Fairness, marking its seventh consecutive year in the top rankings. This significant move up from No. 10 last year showcases Humana's dedication to diversity and inclusion, as recognized by one of the nation's most comprehensive analyses of corporate diversity practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240515913910/en/Humana's culture of inclusion and belonging underscores its commitment to creating a workplace where all employees feel valued and empowered to excel. (Photo: Business Wire) "Providing hig
Humana Inc. (NYSE:HUM) will release its financial results for the second quarter 2024 (2Q24), as well as prepared management remarks (in PDF format), on Wednesday, July 31, 2024, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI4837b56336d1453fb10a8fdaada5e1c0. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique regi
Reports 1Q24 earnings per share (EPS) of $6.11 on a GAAP basis, Adjusted EPS of $7.23 Revises FY 2024 EPS guidance to 'approximately $13.93' (previously 'approximately $14.87') on a GAAP basis, while affirming Adjusted EPS of 'approximately $16.00'; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent Raises 2024 individual Medicare Advantage annual membership growth by 50,000 to now anticipate annual growth of approximately 150,000, or 2.8 percent Continues successful track record of organic expansion in Medicaid with recent contract wins in Florida, Texas, and Virginia Publishes prepared management remarks to Investor Relations page of www.humana.com ah
Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 26, 2024 to stockholders of record as of the close of business on June 28, 2024. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military se
Humana Inc. (NYSE:HUM) will release its financial results for the first quarter 2024 (1Q24), as well as prepared management remarks (in PDF format), on Wednesday, April 24, 2024, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI6d7513be1a494bbb82b4b8caa62d3b2f. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique regi
Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 26, 2024 to stockholders of record as of the close of business on March 29, 2024. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military
Reports 4Q23 loss per share of $4.42 on a GAAP basis, Adjusted loss per share of $0.11; reports FY 2023 earnings per share (EPS) of $20.00 on a GAAP basis, $26.09 on an Adjusted basis 4Q23 results reflect additional increase in Medicare Advantage medical cost trends, driven by higher than anticipated inpatient utilization, primarily for the months of November and December, and a further increase in non-inpatient trends Announces initial FY 2024 EPS guidance of 'approximately $14.87' on a GAAP basis, 'approximately $16.00' on an Adjusted basis; assumes the higher Medicare Advantage medical costs experienced in 4Q23 persist throughout 2024 Affirms 2024 individual Medicare Advantage
Humana Inc. (NYSE:HUM) will release its financial results for the fourth quarter 2023 (4Q23), as well as prepared management remarks (in PDF format), on Thursday, January 25, 2024, at approximately 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. The call was originally scheduled for Monday, February 5, but was rescheduled to provide a more timely update on the company's performance and 2024 guidance. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI4ed0098679fd435e8af0ab344
Humana Inc. (NYSE:HUM) will release its financial results for the fourth quarter 2023 (4Q23) on Monday, February 5, 2024, at 6:30 a.m. Eastern time. The company will host a conference call at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI4ed0098679fd435e8af0ab344fa47655. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique registrant ID. A webcast of the 4Q23 earnings call may also be accessed via
AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IR) of "bbb" (Good) to the recently announced $500 million, 5.75 % senior unsecured notes, due 2028, and the $850 million, 5.95% senior unsecured notes, due 2034, issued by Humana Inc. (Humana) (headquartered in Louisville, KY) (NYSE:HUM). The outlook assigned to these Credit Ratings (ratings) is stable. Humana's Long-Term Issuer Credit Rating of "bbb" (Good), its Long-Term IRs and the ratings of its insurance subsidiaries are unchanged. This issuance is expected to be used to pay down outstanding commercial paper balances and for general corporate purposes. Humana had $1.5 billion of senior unsecured notes mature on Aug. 3,
Reports 3Q23 earnings per share (EPS) of $6.71 on a GAAP basis, Adjusted EPS of $7.78; reports YTD 2023 EPS of $24.26 on a GAAP basis, $26.10 on an Adjusted basis Reflects outperformance in the company's Medicaid and Primary Care businesses along with a continued focus on driving sustainable operating efficiencies, offset by modestly higher than anticipated utilization in the Medicare Advantage business Revises FY 2023 EPS guidance to 'at least $26.31' on a GAAP basis, affirms FY 2023 Adjusted EPS of 'at least $28.25' Raises 2023 individual Medicare Advantage membership growth by 35,000 to 'approximately 860,000', or 19 percent growth over FY 2022 ending membership, meaningfully